Abstract
Myasthenia gravis (MG) associated with anti-muscle-specific tyrosine kinase (MuSK) antibodies differs in many aspects from typical presentation of acetylcholine receptor (AChR)-positive MG. Myopathy and muscle atrophy are observed in MuSK-positive MG patients, unlike AChR-positive patients with MG. That is why the aim of this study was to assess the presence of myopathy and muscle atrophy as well as the tongue lipid composition in our cohort of MuSK-positive MG patients. Clinical examination, electromyography (EMG) and proton magnetic resonance spectroscopy were performed in 31 MuSK-positive and 28 AChR-positive MG patients. Myopathic EMG was more frequent in MuSK compared to AChR MG patients. In AChR MG patients, myopathic EMG in facial muscles was more frequent after long-term corticosteroid treatment, which was not the case with MuSK-positive MG patients. Facial and/or tongue muscle atrophy was registered in 23 % of MuSK MG patients. Longer disease duration was observed in patients with clinical signs of tongue and/or facial muscle atrophy compared to those with normal tongue muscle. Intramyocellular lipid deposition in the tongue was present in 85.2 % of MuSK and 20 % of AChR MG patients. Female MuSK MG patients had more frequently electrophysiological signs of myopathy on the facial muscles and signs of intramyocellular lipid deposition in the tongue, compared to male patients with MuSK-positive MG. Myopathy, muscle atrophy and intramyocellular lipid deposition in the tongue are more frequent in MuSK-positive compared to AChR-positive MG patients.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Lavrnic D, Losen M, Vujic A, De Baets M, Hajdukovic LJ, Stojanovic V et al (2005) The features of myasthenia gravis with autoantibodies to MuSK. J Neurol Neurosurg Psychiatry 76:1099–1102
Sanders DB, El-Salem K, Massey JM, McConville J, Vincent A (2003) Clinical aspects of MuSK antibody positive seronegative MG. Neurology 60:1978–1980
Padua L, Tonali P, Aprile I, Caliandro P, Bartoccioni E, Evoli A (2006) Seronegative myasthenia gravis: comparison of neurophysiological picture in MuSK+ and MuSK− patients. Eur J Neurol 13:273–276
Farrugia ME, Robson MD, Clover L, Anslow P, Newsom-Davis J, Kennett R et al (2006) MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody associated myasthenia gravis. Brain 129:1481–1492
Lavrnic D, Dakovic M, Peric S, Rakocevic-Stojanovic V, Basta I, Marjanovic I et al (2011) Proton magnetic resonance spectroscopy of the intrinsic tongue muscles in patients with myasthenia gravis with different autoantibodies. J Neurol Sci 302:25–28
Jeretzki A 3rd, Barohn RJ, Ernstoff RM, Kaminski HJ, Keesey JC, Penn AS et al (2000) Myasthenia gravis: recommendations for clinical research standards. Task force of the Medical Scientific Advisory Board of the Myasthenia gravis Foundation of America. Neurology 55:16–23
Stål P, Marklund S, Thornell LE, De Paul R, Eriksson PO (2003) Fibre composition of human intrinsic tongue muscles. Cells Tissues Organs 173:147–161
Naressi A, Couturier C, Devos JM, Janssen M, Mangeat C, de Beer R et al (2001) Java-based graphical user interface for the MRUI quantitation package. MAGMA 12:141–152
Vanhamme L, van den Boogaart A, Van Huffel S (1997) Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J Magn Reson 129:35–43
Farrugia ME, Kennett RP, Hilton Jones D, Newsom Davis J, Vincent A (2007) Quantitative EMG of facial muscles in myasthenia patients with MuSK antibody. Clin Neurophysiol 118:269–277
Evoli A, Tonali PA, Padua L, Monaco ML, Scuderi F, Batocchi AP et al (2003) Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis. Brain 126:2304–2311
Evoli A, Batocchi AP, Lo Monaco M, Servidei S, Padua L, Majolini L et al (1996) Clinical heterogeneity of seronegative myasthenia gravis. Neuromuscul Disord 6:155–161
Engel WK, McFarlin DE (1966) Muscle lesions in myasthenia gravis. Ann NY Acad Sci 135:68–78
Rostedt Punga A, Ahlqvist K, Bartoccioni E, Scuderi F, Marino M, Suomalainen A et al (2006) Neurophysiological and mitochondrial abnormalities in MuSK antibody seropositive myasthenia gravis compared to other immunological subtypes. Clin Neurophysiol 117:1434–1443
Pasnoor M, Wolfe G, Nations S, Trivedi J, Barohn RJ, Herbelin L et al (2010) Clinical findings in musk-antibody positive myasthenia gravis: a U.S. experience. Muscle Nerve 41:370–374
Zouvelou V, Rentzos M, Toulas P, Evdokimidis I (2011) MRI evidence of early muscle atrophy in MuSK positive myasthenia gravis. J Neuroimaging 21:303–305
Acknowledgments
This research was supported by the Ministry of Science and Technological Development of the Republic of Serbia (Grants No. 175083 and No. III41005).
The authors wish to thank Radmila Kos, MD, PhD, for the great help with the English language editing.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nikolić, A.V., Bačić, G.G., Daković, M.Ž. et al. Myopathy, muscle atrophy and tongue lipid composition in MuSK myasthenia gravis. Acta Neurol Belg 115, 361–365 (2015). https://doi.org/10.1007/s13760-014-0364-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13760-014-0364-1